Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitorsScott E Wolkenberg, Zhijian Zhao, James J Mulhearn, et al.Bioorganic & Medicinal Chemistry Letters|June 15, 2011
Identification of non-amidine inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Ronald K Chang, Christina N Di Marco, et al.Journal of Economic Entomology|April 13, 2026
Relating rice stink bug (Hemiptera: Pentatomidae) sampling to direct and indirect yield loss in riceJared B Linn, Aaron J Cato, Nicholas R Bateman, et al.ACS Chemical Neuroscience|July 11, 2012
Synthesis, structure-activity relationship, and pharmacological profile of analogs of the ASIC-3 inhibitor A-317567Scott D Kuduk, Christina N Di Marco, Vera Bodmer-Narkevitch, et al.Bioorganic & Medicinal Chemistry Letters|April 3, 2009
Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.Bioorganic & Medicinal Chemistry Letters|June 26, 2009
Amidine derived inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Ronald K Chang, Jenny M-C Wai, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 31, 2007
In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophreniaLee A Dawson, Katherine J Cato, Claire Scott, et al.Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamidesKausik K Nanda, M Brad Nolt, Matthew J Cato, et al.Bioorganic & Medicinal Chemistry Letters|January 30, 2017
Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokineticsScott E Wolkenberg, M Brad Nolt, Mark T Bilodeau, et al.Bioorganic & Medicinal Chemistry Letters|May 4, 2017
Benzoxazolinone aryl sulfonamides as potent, selective Na<sub>v</sub>1.7 inhibitors with in vivo efficacy in a preclinical pain modelJoseph E Pero, Michael A Rossi, Hannah D G F Lehman, et al.Pageof 3